| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 5 |
| 1 | ABATACEPT | 4 |
| 2 | ACETAMINOPHEN | 2 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 |
| 4 | CERTOLIZUMAB PEGOL | 2 |
| 5 | LEVOTHYROXINE SODIUM | 2 |
| 6 | METHOTREXATE | 2 |
| 7 | METHOTREXATE SODIUM | 2 |
| 8 | PREDNISOLONE | 2 |
| 9 | PREDNISOLONE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 2 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 3 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 4 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 5 | UBROGEPANT | 1 | 0.0002 |
| 6 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| 7 | RIZATRIPTAN BENZOATE | 1 | 0.0001 |
| 8 | ROTIGOTINE | 1 | 0.0001 |
| 9 | RISEDRONATE SODIUM | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 2 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Progesterone [EPC] | 1 | 0.0000 |
| 5 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 4 | 0.0000 |
| 8 | Methylxanthine [EPC] | 1 | 0.0000 |
| 9 | Catecholamine [EPC] | 1 | 0.0000 |